334 related articles for article (PubMed ID: 30446625)
1. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
2. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
[TBL] [Abstract][Full Text] [Related]
3. Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.
Acevedo DS; Fang WB; Rao V; Penmetcha V; Leyva H; Acosta G; Cote P; Brodine R; Swerdlow R; Tan L; Lorenzi PL; Cheng N
Neoplasia; 2022 Jun; 28():100791. PubMed ID: 35405500
[TBL] [Abstract][Full Text] [Related]
4. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
5. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
[TBL] [Abstract][Full Text] [Related]
6. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
7. Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression.
Fang WB; Sofia Acevedo D; Smart C; Zinda B; Alissa N; Warren K; Fraga G; Huang LC; Shyr Y; Li W; Xie L; Staggs V; Hong Y; Behbod F; Cheng N
Sci Rep; 2021 Apr; 11(1):8708. PubMed ID: 33888841
[TBL] [Abstract][Full Text] [Related]
8. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
[TBL] [Abstract][Full Text] [Related]
9. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/Src Pathway in HER2-positive Breast Cancer Cells.
You D; Kim H; Jeong Y; Yoon SY; Lo E; Lee JE; Kim S
Anticancer Res; 2023 Mar; 43(3):1079-1089. PubMed ID: 36854521
[TBL] [Abstract][Full Text] [Related]
12. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
Lu X; Kang Y
J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
[TBL] [Abstract][Full Text] [Related]
13. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
[TBL] [Abstract][Full Text] [Related]
14. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
15. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
[TBL] [Abstract][Full Text] [Related]
16. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
17. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M; Wang Y; Xia R; Wei Y; Wei X
Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
[TBL] [Abstract][Full Text] [Related]
18. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
[TBL] [Abstract][Full Text] [Related]
19. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
Izumi K; Fang LY; Mizokami A; Namiki M; Li L; Lin WJ; Chang C
EMBO Mol Med; 2013 Sep; 5(9):1383-401. PubMed ID: 23982944
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]